These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16495375)

  • 1. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.
    Mishra KK; Puri DR; Missett BT; Lamborn KR; Prados MD; Berger MS; Banerjee A; Gupta N; Wara WM; Haas-Kogan DA
    Neuro Oncol; 2006 Apr; 8(2):166-74. PubMed ID: 16495375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute.
    Turkoglu E; Gurer B; Sanli AM; Dolgun H; Gurses L; Oral NA; Donmez T; Sekerci Z
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2508-13. PubMed ID: 24225484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
    Sanai N; Polley MY; Berger MS
    J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades.
    Youland RS; Khwaja SS; Schomas DA; Keating GF; Wetjen NM; Laack NN
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):197-205. PubMed ID: 22983418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.
    Mishra KK; Squire S; Lamborn K; Banerjee A; Gupta N; Wara WM; Prados MD; Berger MS; Haas-Kogan DA
    J Neurooncol; 2010 Oct; 100(1):121-7. PubMed ID: 20221671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of childhood glial tumors, management approaches and life expectancy of the patients.
    Arslan A; Guney Y; Cihan YB; Cetindag MF
    J BUON; 2014; 19(3):724-32. PubMed ID: 25261659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult low-grade glioma: 19-year experience at a single institution.
    Youland RS; Brown PD; Giannini C; Parney IF; Uhm JH; Laack NN
    Am J Clin Oncol; 2013 Dec; 36(6):612-9. PubMed ID: 22892428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
    Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
    Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.
    Huynh-Le MP; Walker AJ; Burger PC; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
    Childs Nerv Syst; 2016 Aug; 32(8):1425-30. PubMed ID: 27179530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
    Chang EF; Smith JS; Chang SM; Lamborn KR; Prados MD; Butowski N; Barbaro NM; Parsa AT; Berger MS; McDermott MM
    J Neurosurg; 2008 Nov; 109(5):817-24. PubMed ID: 18976070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upfront observation versus radiation for adult pilocytic astrocytoma.
    Ishkanian A; Laperriere NJ; Xu W; Millar BA; Payne D; Mason W; Sahgal A
    Cancer; 2011 Sep; 117(17):4070-9. PubMed ID: 21391213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective clinical trials of intracranial low-grade glioma in adults and children.
    Shaw EG; Wisoff JH
    Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
    Devaux BC; O'Fallon JR; Kelly PJ
    J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children's Oncology Group.
    Wisoff JH; Sanford RA; Heier LA; Sposto R; Burger PC; Yates AJ; Holmes EJ; Kun LE
    Neurosurgery; 2011 Jun; 68(6):1548-54; discussion 1554-5. PubMed ID: 21368693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
    Youland RS; Kreofsky CR; Schomas DA; Brown PD; Buckner JC; Laack NN
    J Neurooncol; 2017 Dec; 135(3):535-543. PubMed ID: 28836106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.